Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.

The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

Hims & Hers has shown impressive revenue growth, accelerating from 46% to 77%. Read why I downgrade HIMS stock from buy to ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Hims’ hair care lineup does a great job supporting your existing ... Still, I wish they had a ketoconazole option for shampoo, since it would work so effectively in their hair loss lineup.

In today’s world, erectile dysfunction (ED) affects millions of men, causing emotional and psychological distress.

Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

Hims takes a more practical approach to weight loss, offering prescription weight loss treatment designed to fit you, including FDA-approved medications proven to work. Address underlying factors ...

Although the ad does not identify the medication, Hims & Hers offers compounded versions of the weight-loss drug semaglutide, which was developed by Novo Nordisk and is typically sold under the ...